NOVEL USE OF TRITOQUALINE FOR THE TREATMENT OF INFLAMATORY DISEASES DIGESTIVE AND MORE PARTICULARLY GASTRIC AND ESOPHAGEAL

摘要

The present invention relates to the novel use of chemical substances, the levogyric and dextrorotatory enantiomers of (AMINO-7 TRIETHOXY-4,5,6 OXO-1-1,3-DIHYDRO-ISOBENZOFURANNYL-3) -1METHOXY-8-METHYL-2-METHYLENEDIOXY- 6,7TETRAHYDRO-, 2,3,4-ISOQUINOLINE or tritoqualine, in inflammatory diseases concerning the digestive sphere and more particularly gastric diseases.